15-Nov-2026 22:44:29
ANGGeneral news
ANG LIFESCIENCES INDIA Q2 FY27 ; CONS NET LOSS AT ₹2.09 CR VS LOSS ₹2.95 CR (YOY), VS LOSS ₹4.24 CR (QOQ)
REVENUE DOWN 22.85% AT ₹20.10 CR (YOY), UP 31.39% (QOQ) EBITDA LOSS AT ₹0.26 CR VS PROFIT ₹0.08 CR (YOY), VS LOSS ₹1.95 CR (QOQ) MARGINS AT -1.31% VS 0.31% (YOY), -12.77% (QOQ)
ANG Lifesciences India Limited